Epimorphin is a novel regulator of the progesterone receptor isoform-A

Cancer Research

Volumn 73, Issue 18, 2013, Pages 5917-5929

  Bascom, Jamie L ^a   Radisky, Derek C ^b   Koh, Eileen ^a   Fata, Jimmie E ^c   Lo, Alvin ^a   Mori, Hidetoshi ^a   Roosta, Neda ^a   Hirai, Yohei ^d   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD51 ANTIGEN; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE RECEPTOR A; STROMELYSIN; SYNTAXIN 2; EPIM PROTEIN, MOUSE; HORMONE ANTAGONIST; MEMBRANE PROTEIN; MILK PROTEIN; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR B; WHEY ACIDIC PROTEINS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; APOPTOSIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; UDDER; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; HORMONE ANTAGONISTS; HUMANS; MALE; MAMMARY GLANDS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MIFEPRISTONE; MILK PROTEINS; PHENOTYPE; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84884786652     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0021     Document Type: Article

References (45)

1. Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 2002;7:39-48.
2. Shyamala G. Roles of estrogen and progesterone in normal mammary gland development insights from progesterone receptor null mutant mice and in situ localization of receptor. Trends Endocrinol Metab 1997;8:34-9.
3. Imagawa W, Pedchenko VK, Helber J, Zhang H. Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002;80:213-30.
4. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, Choi Y, et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A. 2010; 107:2989-94.
5. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-65.
6. Hirai Y, Takebe K, Takashina M, Kobayashi S, Takeichi M. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 1992;69:471-81.
7. Bennett MK, Garcia-Arraras JE, Elferink LA, Peterson K, Fleming AM, Hazuka CD, et al. The syntaxin family of vesicular transport receptors. Cell 1993;74:863-73.
8. Woodman PG. The roles of NSF, SNAPs and SNAREs during membrane fusion. Biochim Biophys Acta 1997;1357:155-72.
9. Radisky DC, Hirai Y, Bissell MJ. Delivering the message: epimorphin and mammary epithelial morphogenesis. Trends Cell Biol 2003;13: 426-34.
10. Radisky DC, Stallings-Mann M, Hirai Y, Bissell MJ. Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat Rev Mol Cell Biol 2009;10:228-34.
11. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ. Epimorphin functions as a key morphoregulator formammary epithelial cells. J Cell Biol 1998;140:159-69.
12. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001;128:3117-31.
13. Hirai Y, NelsonCM,Yamazaki K, Takebe K, Przybylo J, Madden B, et al. Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesis. J Cell Sci 2007;120: 2032-43.
14. Hirai Y, Radisky D, Boudreau R, Simian M, Stevens ME, Oka Y, et al. Epimorphin mediates mammary luminal morphogenesis through control of C/EBPb. J Cell Biol 2001;153:785-94.
15. Bascom JL, Fata JE, Hirai Y, Sternlicht MD, Bissell MJ. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res 2005;65: 8617-21.
16. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci U S A 1998;95:696-701.
17. Simian M, Bissell MJ, Barcellos-Hoff MH, Shyamala G. Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. Breast Cancer Res 2009;11:R72.
18. Chou YC, Uehara N, Lowry JR, Shyamala G. Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation. Carcinogenesis 2003;24:403-9.
19. Aupperlee MD, Drolet AA, Durairaj S, Wang W, Schwartz RC, Haslam SZ. Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology 2009;150:1485-94.
20. Jia Y, Yao H, Zhou J, Chen L, Zeng Q, Yuan H, et al. Role of epimorphin in bile duct formation of rat liver epithelial stem-like cells: involvement of small G protein RhoA and C/EBPb. J Cell Physiol 2011;226: 2807-16.
21. Fata JE, Mori H, Ewald AJ, Zhang H, Yao E, Werb Z, et al. The MAPK (ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev Biol 2007;306:193-207.
22. Xu R, Nelson CM, Muschler JL, Veiseh M, Vonderhaar BK, Bissell MJ. Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function. J Cell Biol 2009;184: 57-66.
23. Takebe K, Oka Y, Radisky D, Tsuda H, Tochigui K, Koshida S, et al. Epimorphin acts to induce hair follicle anagen in C57BL/6 mice. Faseb J 2003;17:2037-47.
24. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006;314:298-300.
25. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-78.
26. Pittius CW, Hennighausen L, Lee E, Westphal H, Nicols E, Vitale J, et al. A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci U S A 1988;85:5874-8.
27. Robinson GW, McKnight RA, Smith GH, Hennighausen L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995;121:2070-90.
28. Chen CS, Nelson CM, Khauv D, Bennett S, Radisky ES, Hirai Y, et al. Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis. J Biol Chem 2009;284:6877-84.
29. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 1998;95:5076-81.
30. Shyamala G, Schneider W, Schott D. Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 1990;126:2882-9.
31. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008;14:570-81.
32. Imagawa W, Tomooka Y, Hamamoto S, Nandi S. Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology 1985;116:1514-24.
33. Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, et al. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology 2011;54: 1808-18.
34. Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY. Prevention of Brca1- mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 2006;314:1467-70.
35. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissuespecific gene expression. J Cell Biol 1994;125:681-93.
36. Sympson CJ, Bissell MJ, Werb Z. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Semin Cancer Biol 1995;6:159-63.
37. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
38. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, et al. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 2003;162:1123-33.
39. Lange CA. Challenges to defining a role for progesterone in breast cancer. Steroids 2008;73:914-21.
40. Dressing GE, Hagan CR, Knutson TP, Daniel AR, Lange CA. Progesterone receptors act as sensors formitogenic protein kinases in breast cancer models. Endocr Relat Cancer 2009;16:351-61.
41. Lamote I, Meyer E, Massart-Leen AM, Burvenich C. Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution. Steroids 2004;69:145-59.
42. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009;23:2563-77.
43. Keshgegian AA, Cnaan A. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome. Arch Pathol Lab Med 1996;120:970-3.
44. Nikolic-Vukosavljevic D, Kanjer K, Neskovic-Konstantinovic Z, Vukotic D. Natural history of estrogen receptor-negative, progesterone receptor- positive breast cancer. Int J Biol Markers 2002;17:196-200.
45. Giersig C. Progestin and breast cancer. The missing pieces of a puzzle. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008;51:782-6.